[{"id":"d93d2f4a-522f-4c65-aaf9-278e639f8087","acronym":"","url":"https://clinicaltrials.gov/study/NCT01554254","created_at":"2021-01-18T06:34:45.579Z","updated_at":"2024-07-02T16:37:29.438Z","phase":"Phase 2","brief_title":"Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation","source_id_and_acronym":"NCT01554254","lead_sponsor":"Tarix Pharmaceuticals","biomarkers":" HLA-DRB1","pipe":"","alterations":" ","tags":["HLA-DRB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TXA-127"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 03/01/2012","start_date":" 03/01/2012","primary_txt":" Primary completion: 12/01/2013","primary_completion_date":" 12/01/2013","study_txt":"","study_completion_date":"","last_update_posted":"2016-08-31"}]